Results 101 to 110 of about 19,002 (159)

Anti-tumor efficacy of anti-Dll4 (REGN1035) and/or anti-VEGF (sunitinib or ziv-aflibercept) in RP-R-01 and RP-R-02 ccRCC patient derived xenografts.

, 2014
Mice (8 mice/group) were treated with vehicle, sunitinib, or ziv-aflibercept and/or REGN1035. Left panel: Tumor growth curves. (A) RP-R-01 REGN1035 and/or sunitinib treatment groups (B) RP-R-01 REGN1035 and/or ziv-aflibercept treatment groups (C) RP-R-02
Mukund Seshadri (659823), Paula Sotomayor (186059), Alshad S. Lalani (659826), Li Shen (110858), Kiersten Marie Miles (659822), Dylan Conroy (659824), Frank Kuhnert (659825), Bryan Gillard (527902), Gavin Thurston (659827), Remi Adelaiye (197585), Roberto Pili (186063), Eric Ciamporcero (155252), Kristopher Attwood (318112)   +12 more
core   +1 more source

Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?

Cancer Management and Research, 2013
Muhammad Wasif Saif GI Oncology Program, Tufts University School of Medicine, Boston, MA, USA Abstract: Bevacizumab is a monoclonal antibody that binds and neutralizes vascular endothelial growth factor (VEGF)-A, a key player in the angiogenesis pathway.
Saif MW
doaj  

Effects of REGN1035 and/or ziv-aflibercept on tumor cell proliferation in RP-R-01 ccRCC xenograft.

, 2014
Mice were treated with vehicle, ziv-aflibercept and/or REGN1035. Tumors were harvested, processed, and tissue sections were stained for differential expression of Ki67. (A) Representative images.
Mukund Seshadri (659823), Paula Sotomayor (186059), Alshad S. Lalani (659826), Li Shen (110858), Kiersten Marie Miles (659822), Dylan Conroy (659824), Frank Kuhnert (659825), Bryan Gillard (527902), Gavin Thurston (659827), Remi Adelaiye (197585), Roberto Pili (186063), Eric Ciamporcero (155252), Kristopher Attwood (318112)   +12 more
core   +1 more source

Regression in polypoidal choroidal vasculopathy treated with ziv-aflibercept monotherapy - short term study. [PDF]

Saudi J Ophthalmol, 2021
Mishra SB, Singh SR, Goyal P, Chakurkar R, Govindhari V, Goud A, Chhablani J.   +6 more
europepmc   +1 more source

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

, 2012
Purpose To compare the efficacy of aflibercept (ziv-aflibercept), a recombinant human fusion protein targeting the vascular endothelial growth factor (VEGF) pathway, with or without docetaxel in platinum-pretreated patients with advanced or metastatic ...
Ciuleanu, Tudor Eliade, Rey, Augustin, Ozguroglu, Mustafa, Goksel, Tuncay, Bennouna, Jaafar, Scagliotti, Giorgio, Shepherd, Frances A., Miller, Vincent, Thatcher, Nicholas, Novello, Silvia, Ramlau, Rodryg, Baldotto, Clarissa, Gorbunova, Vera, Le-Guennec, Solenn   +13 more
core   +1 more source

Ziv-Aflibercept [PDF]

, 2020
openaire   +1 more source

Efficacy of intravitreal ziv-aflibercept in patients with macular edema following retinal vein occlusion in Korle-Bu Teaching Hospital, Ghana: a retrospective case series. [PDF]

Int Ophthalmol, 2021
Braimah IZ, Agyabeng K, Amoaku WM.
europepmc   +1 more source

Irinotecan/Ziv-aflibercept Regimen [PDF]

, 2020
openaire   +1 more source

Cancer Metastases to the Liver: Mechanisms of Tumor Cell Colonization

Pharmaceuticals
The liver is one of the most common sites for metastasis, which involves the spread from primary tumors to surrounding organs and tissues in the human body.
Wiktoria Andryszkiewicz, Piotr Misiąg, Anna Karwowska, Zofia Resler, Aleksandra Wojno, Julita Kulbacka, Anna Szewczyk, Nina Rembiałkowska   +7 more
doaj   +1 more source

FOLFIRI/Ziv-aflibercept Regimen [PDF]

, 2020
openaire   +1 more source